| Prev Close | 46.79 |
| Open | 46.50 |
| Day Low/High | 44.91 / 46.50 |
| 52 Wk Low/High | 42.01 / 58.31 |
| Volume | 3.21M |
| Avg Volume | 2.72M |
Cardinal Health Inc. (CAH)
45.07
1.70
3.70
NYSE : Distribution Services
| Exchange | NYSE |
| Shares Outstanding | 298.06M |
| Market Cap | 14.16B |
| EPS | 0.80 |
| P/E Ratio | 2,375.00 |
| Div & Yield | 1.92 (4.01%) |
Latest News
McKesson or Cardinal Health: Which Is a Better Dividend Yield Buy?
Cardinal Health and McKesson have similar business models, but they are very different stocks.
Trade Deals, Climate Change Stock Picks, Chipotle Rebounds: Market Recon
Does it not make sense to create a separate portfolio made up of equities that will benefit -- as sick as that sounds -- when an area needs to rebuild?
Biotech and Beyond: 8 Favorite Healthcare Stocks for 2019
From small-cap genetics and biotech firms to large-cap drug distributors and pharmacies, eight experts select their top picks in the space for this year.
Time to Minimize Your Tax Bill With Tax-Loss Selling
Underwater positions on stocks you feel lukewarm about are prime candidates for tax selling.
Cardinal Health Stock Has Formed a Bullish Reversal Pattern
CAH has managed to move above high volume resistance at the $54.50 level that has been a barrier since June.
11 Top Income Stocks With Enticing Yields and Attractive Dividend Growth
These names combine good dividend yields with a track record of raising quarterly payouts.
'Death by Amazon' Greatly Exaggerated
Contrarians who bought several "dead men walking" retailers have pocketed big gains by defying conventional wisdom.
CAH Is Among the Best Blue Chip Values
Buy Cardinal Health and give it time for the market to reassess the industry.
Four Cheap 'Dividend Aristocrats' to Buy Now
These stocks are selling at historically low earnings multiples, but have raised their dividends for decades.
Intermediate Trade: Cardinal Health
CAH now rates as a covered call candidate.
Cardinal Health: Top Quality, Major Upside
Short-term pain should lead to long-term gains, especially for investors buying in now.
2 Stocks That Look Real Good to Short
These 'bearish bets' show weak technical characteristics and have received recent quant downgrades.
Jim Cramer: It's All About Expectations
Earnings season is already seeing some wacky effects.
Could Bitcoin Become as Savvy an Investment as Nvidia?
Bitcoin, the bull market, and Amazon -- oh my! This is what you can't miss Wednesday.
What's Behind the Hound of Hades' Stock Market Rampage
The free market is going to take back control of interest rates.
The 5 Best 'Dividend Aristocrats' for 2018
The best high-yielding blue chips at discounted prices.
How to Trade the Saudi Arabia Anti-Corruption Moves: Market Recon
The Saudi Arabian economy needs to rebalance away from oil.
Positive Signs in Drug Distribution
Blockbuster drugs still need companies to deliver them.
Cramer: Finding the Flaws in Amazon
Other companies are starting to catch up.
Trader's Daily Notebook: Apple's Chart Looks Really Good
I would look to begin trading it on the long side above $160.
Cramer: The Rebound is Real. Now What?
With stocks rebounding, investors face a tough choice.
Cardinal Health Is Not Responding to Care
It looks like CAH will have a long road to recovery.
Play the Dip in Cardinal Health
News of acquisition hits this high-quality stock; here's your chance.
Top 5 Dividend Stocks to Buy Now for 2017
Here is a look at some stocks that are poised for excellent dividend returns in 2017.
Cramer: Nike Is a Victim of Price Wars; There Will Be Others
Look out below when it comes to margins, as the price wars extend to sneakers, drugs and others.
